Wells Fargo & Company Savara Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Savara Inc stock. As of the latest transaction made, Wells Fargo & Company holds 41,491 shares of SVRA stock, worth $130,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,491

Previous 33,335 24.47%

Holding current value

$130,696

Previous $134,000 30.6%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.96 - $5.07 $32,297 - $41,350	8,156 Added 24.47%	41,491 $175,000
Q2 2024 Aug 13, 2024	SELL	$3.66 - $5.34 $1,207 - $1,762	-330 Reduced 0.98%	33,335 $134,000
Q1 2024 May 10, 2024	BUY	$4.19 - $5.59 $14,945 - $19,939	3,567 Added 11.85%	33,665 $167,000
Q4 2023 Feb 09, 2024	BUY	$3.18 - $4.9 $25,395 - $39,131	7,986 Added 36.12%	30,098 $141,000
Q3 2023 Nov 13, 2023	SELL	$2.97 - $3.88 $21,125 - $27,598	-7,113 Reduced 24.34%	22,112 $83,000
Q2 2023 Aug 15, 2023	BUY	$1.69 - $3.24 $48,497 - $92,978	28,697 Added 5435.04%	29,225 $93,000
Q1 2023 May 12, 2023	BUY	$1.6 - $2.82 $12 - $22	8 Added 1.54%	528 $1,000
Q4 2022 Feb 13, 2023	BUY	$1.11 - $1.64 $14 - $21	13 Added 2.56%	520 $0
Q3 2022 Nov 14, 2022	SELL	$1.36 - $1.88 $58 - $80	-43 Reduced 7.82%	507 $1,000
Q2 2022 Aug 12, 2022	BUY	$1.1 - $1.58 $49 - $71	45 Added 8.91%	550 $1,000
Q1 2022 May 16, 2022	BUY	$1.05 - $1.36 $2 - $2	2 Added 0.4%	505 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.04 - $1.34 $3,118 - $4,018	-2,999 Reduced 85.64%	503 $1,000
Q3 2021 Nov 15, 2021	SELL	$1.18 - $1.64 $3,706 - $5,151	-3,141 Reduced 47.28%	3,502 $5,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.29 $24,019 - $36,427	-15,907 Reduced 70.54%	6,643 $11,000
Q1 2021 May 13, 2021	SELL	$1.17 - $2.33 $85,631 - $170,530	-73,189 Reduced 76.45%	22,550 $46,000
Q4 2020 Feb 09, 2021	SELL	$1.0 - $1.47 $73,188 - $107,586	-73,188 Reduced 43.33%	95,739 $110,000
Q3 2020 Nov 05, 2020	SELL	$1.09 - $2.21 $157,930 - $320,206	-144,890 Reduced 46.17%	168,927 $184,000
Q2 2020 Aug 13, 2020	BUY	$1.8 - $3.05 $527,749 - $894,241	293,194 Added 1421.68%	313,817 $781,000
Q1 2020 May 14, 2020	BUY	$1.91 - $4.08 $39,389 - $84,141	20,623 New	20,623 $44,000

Others Institutions Holding SVRA

# of Institutions

128

Shares Held

158M

Call Options Held

67.6K

Put Options Held

29.4K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $359M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Savara Inc Transaction History